Pentwater Capital cuts Faron Pharmaceuticals stake below 3% via cash-settled swap

Reuters2026/09/04 10:04

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Pentwater Capital Management cut its exposure in Faron Pharmaceuticals below the 3% disclosure threshold via cash-settled swap instruments.
The move took effect on Sep. 1, 2026, down from a previously disclosed 3.88% held through financial instruments.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Faron Pharmaceuticals Oyj published the original content used to generate this news brief on September 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Pentwater Capital cuts Faron Pharmaceuticals stake below 3% via cash-settled swap

You may also like

Crypto prices